A proposed acquisition of workforce management firm Dayforce by private equity group Thoma Bravo is facing formal scrutiny. The investigation, initiated by shareholder rights litigation firm Halper Sadeh LLC, centers on whether the $70 per share all-cash offer adequately reflects the true value of Dayforce stock and whether the company’s board has fulfilled its fiduciary duties to shareholders.
The $70 per share acquisition price forms the core of this examination. Halper Sadeh is investigating potential breaches of securities laws and fiduciary responsibilities in connection with the proposed transaction. Such legal reviews are a standard feature of significant merger and acquisition activity, serving to protect the interests of minority shareholders.
Despite the ongoing investigation, Dayforce’s stock has demonstrated notable stability. Shares are currently trading near $68.99, hovering just below the acquisition offer price. This trading pattern suggests strong market confidence that the transaction will ultimately be completed. Recent trading volume reached approximately 1.3 million shares, sitting about 1% below the stock’s average volume.
Should investors sell immediately? Or is it worth buying Ceridian HCM?
Key Transaction Details:
* Thoma Bravo has presented an all-cash offer of $70 per share
* The company recently rebranded from Ceridian HCM Holding Inc. in February 2024
* The ticker symbol concurrently changed from CDAY to DAY
* A formal investigation into the fairness of the offer is currently underway
The ongoing legal review could potentially lead to additional disclosures regarding the acquisition terms or even a renegotiation of the offer price if substantiated concerns emerge. The current market performance indicates investor expectation that the deal will proceed as announced. The final outcome of this acquisition process will significantly shape the future trajectory of Dayforce and its investor community.
Ad
Ceridian HCM Stock: Buy or Sell?! New Ceridian HCM Analysis from September 17 delivers the answer:
The latest Ceridian HCM figures speak for themselves: Urgent action needed for Ceridian HCM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 17.
Ceridian HCM: Buy or sell? Read more here...